Sugarloaf Wealth Management, LLC - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M605. A total of 15 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Sugarloaf Wealth Management, LLC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q3 2023$10.0%10.0%0.00%–
Q2 2023$10.0%10.0%0.00%–
Q1 2023$1
-50.0%
10.0%0.00%–
Q4 2022$2
-99.8%
10.0%0.00%–
Q3 2022$1,000–10.0%0.00%–
Q2 2022$0–1–0.00%–
 Download
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q3 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 1,752$7,0000.00%
Renaissance Technologies 27,725$119,0000.00%
ROYAL BANK OF CANADA 70$00.00%
VANGUARD GROUP INC 16,946$73,0000.00%
UBS Group AG 5,540$24,0000.00%
IFP Advisors, Inc 1$1,0000.00%
TWO SIGMA INVESTMENTS, LP 11,521$49,0000.00%
Sugarloaf Wealth Management, LLC 1$1,0000.00%
OSAIC HOLDINGS, INC. 7$00.00%
WELLS FARGO & COMPANY/MN 9$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders